Abstract:Background: Constipation is a prevalent gastrointestinal disorder affecting approximately 15% of the global population, leading to significant healthcare burdens. Emerging evidence suggests that gut microbiota plays a pivotal role in the pathogenesis of constipation, although causality remains uncertain due to potential confounding factors in observational studies. This study aims to clarify the causal relationships between gut microbiota and constipation using a bidirectional Mendelian Randomization (MR) approach, which helps to overcome confounding issues and reverse causality. Methods: Utilizing data from genome-wide association studies (GWAS) from the MiBioGen consortium and other sources, we identified genetic variants as instrumental variables (IVs) for 196 bacterial traits and constipation. These IVs were rigorously selected based on their association with the traits and absence of linkage with confounding factors. We applied several MR methods, including Inverse Variance Weighted (IVW), MR Egger, and MR-PRESSO, to examine the causal effects in both directions. Results: Our analysis revealed a significant causal relationship where specific bacterial taxa such as Coprococcus1 (OR = 0.798, 95%CI: 0.711–0.896, p < 0.001), Coprococcus3 (OR = 0.851, 95%CI: 0.740–0.979, p = 0.024), Desulfovibrio (OR = 0.902, 95%CI: 0.817–0.996, p = 0.041), Flavonifracto r (OR = 0.823, 95%CI: 0.708–0.957, p < 0.001), and Lachnospiraceae UCG004 , whereas others including Ruminococcaceae UCG005 (OR = 1.127, 95%CI: 1.008–1.261, p = 0.036), Eubacterium nodatum group (OR = 1.080, 95%CI: 1.018–1.145, p = 0.025), Butyricimonas (OR = 1.118, 95%CI: 1.014–1.233, p = 0.002), and Bacteroidetes (OR = 1.274, 95%CI: 1.014–1.233, p < 0.001) increase constipation risk. In the reverse MR analysis, constipation was found to influence the abundance of certain taxa, including Family XIII , Porphyromonadaceae , Proteobacteria , Lentisphaeria , Veillonellaceae , Victivallaceae , Catenibacterium , Sellimonas , and Victivallales , indicating a bidirectional relationship. Sensitivity analyses confirmed the robustness of these findings, with no evidence of heterogeneity or horizontal pleiotropy. Conclusion: The relationship between our study gut microbiota and constipation interacts at the genetic level, which gut microbiota can influence the onset of constipation, and constipation can alter the gut microbiota. Coprococcus1 , Coprococcus3 , Desulfovibrio , Flavonifractor and Lachnospiraceae UCG004 play a protective role against constipation, while Ruminococcaceae UCG005 , Eubacterium nodatum group , Butyricimonas , and Bacteroidetes are associated with an increased risk. In addition, constipation correlates positively with the abundance of Family XIII , Porphyromonadaceae and Proteobacteria , while negatively with Lentisphaeria , Veillonellaceae , Victivallaceae , Catenibacterium , Sellimonas , and Victivallales .

Differential Gut Microbiota, Dietary Intakes in Constipation Patients with or without Hypertension

Intestinal microbiome changes and mechanisms of maintenance hemodialysis patients with constipation

Supplementary Material For: Specific Alterations of Gut Microbiota in Chinese Patients with Hypertension: A Systematic Review and Meta-Analysis

Non-isoflavones Diet Incurred Metabolic Modifications Induced by Constipation in Rats Via Targeting Gut Microbiota

Causal relationship between gut microbiota and constipation: a bidirectional Mendelian randomization study

Gut Microbiota Dysbiosis In Human Hypertension: A Systematic Review Of Observational Studies

Association Between Dietary Intake of Live Microbes and Chronic Constipation in Adults.

Gut microbiota changes in patients with hypertension: A systematic review and meta‐analysis

Gut microbiota dysbiosis contributes to the development of hypertension

Influence of Dietary Components and Traditional Chinese Medicine on Hypertension: A Potential Role for Gut Microbiota

Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial

The gut microbiome and metabolites are altered and interrelated in patients with functional constipation

Abundance of Probiotics and Butyrate-Production Microbiome Manages Constipation via Short-Chain Fatty Acids Production and Hormones Secretion

Different Gastrointestinal Microbiota Related to Bile-Acid Metabolism in Hypertensive Patients With or Without Nephropathy

Gut microbial metabolic flux disorder in hypertension

Intestinal Microbiota and Chronic Constipation

Molecular Characterization of Alterations in the Intestinal Microbiota of Patients with Grade 3 Hypertension

Unique intestinal microflora and metabolic profile in different stages of hypertension reveal potential biomarkers for early diagnosis and prognosis

Characteristics of the Gut Microbiome and Serum Metabolome in Patients with Functional Constipation

Gut microbiota and hypertension: association, mechanisms and treatment

Analysis of factors associated with constipation in the population with obesity: Evidence from the National Health and Nutrition Examination Survey